The two-and-a-half-year-old Zeenia, hailing from Sahiwal inPakistan, was suffering from Hemaphagocytic Lymphohistiocytosis (HLH), a rare disease in which bone marrow produces some abnormal cells which eat away the normalcells, resulting in high fever, low blood counts,liver and spleen enlargement, doctors said.
Calling it a potentially life threatening disorder, doctors said the only cure for this condition was bone marrow transplant. Zeenia was also diagnosed to have partial albinism since birth as well, they added.
"As the donor is just eight months old to collect the adequate dosage, he was required to undergo the donation process twice at a gap of only few weeks," Dr Bhat said.
"By using small marrow extraction needles and with the assistance of a team of anesthetists and other members, we have successfully extracted enough marrow which helped cure Zeenia. Rayan has not only saved his sister, he also has the unique distinction of being the youngest marrow donor in India," he added.
The doctors also said Rayan was doing "exceptionally" well and fine.
Zeenia had earlier undergone treatment at an armed forces hospital in Rawalpindi.
Stating that there was "general fear factor" when they landed in India, Zeenia's father Zia Ulla said his daughter wasnow fine and recovering.
"From the time we landed following immigrationI would say it was a very pleasant surprise ... Everyone was very fine and friendly," he said.
Dr Sharat Damodar, Senior Consultant Hematologist and Clinical Director, Narayana Health City, said there was lot ofmisconception about bone marrow transplant like donor infecting diseases and others, "which is not true."
He said "if we compare India with United States which does about 10,000 transplants a year, our numbers are not even touching 2,000. For the size of India's population which is four or five times the population of the US, the country should be doing five times that number."
Dr Bhat said Narayana Health sees about 40-oddpatients from abroad getting transplants every year whichamounts to 30 to 40 per cent.They come here because of non-availability of treatment in their respective countries, and cost worthiness compared to US and Europe, he said.
The division, which was doing on an average 60-70 transplants per year when started, is now doing about 150 per year.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
